Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5713704 | American Journal of Otolaryngology | 2016 | 4 Pages |
Abstract
Compared to p16â recurrent tumor patients, p16+ recurrent tumor patients were more likely to experience regional or distant metastatic recurrence. Overall outcomes for both p16+ and p16â recurrent oropharynx tumors were poor.
Related Topics
Health Sciences
Medicine and Dentistry
Otorhinolaryngology and Facial Plastic Surgery
Authors
Chase M. MD, Karina Yu, Sarah MD, Jonathan R. MD, William R. MD, Steven J. MD,